OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
50
Views
25
CrossRef citations to date
0
Altmetric
Case Series
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
Shen-Cun Fang1 Department of Respiratory Medicine Center, Nanjing Chest Hospital;2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China
, Hai-Tao Zhang1 Department of Respiratory Medicine Center, Nanjing Chest Hospital
, Ying-Ming Zhang1 Department of Respiratory Medicine Center, Nanjing Chest HospitalCorrespondence[email protected]
& Wei-Ping Xie2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
Pages 447-452
|
Published online: 18 Jan 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.